vorinostat has been researched along with Benign Supratentorial Neoplasms in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milde, T | 1 |
| Kleber, S | 1 |
| Korshunov, A | 1 |
| Witt, H | 1 |
| Hielscher, T | 1 |
| Koch, P | 1 |
| Kopp, HG | 1 |
| Jugold, M | 1 |
| Deubzer, HE | 1 |
| Oehme, I | 1 |
| Lodrini, M | 1 |
| Gröne, HJ | 1 |
| Benner, A | 1 |
| Brüstle, O | 1 |
| Gilbertson, RJ | 1 |
| von Deimling, A | 1 |
| Kulozik, AE | 1 |
| Pfister, SM | 1 |
| Martin-Villalba, A | 1 |
| Witt, O | 1 |
| Kumar, KS | 1 |
| Sonnemann, J | 1 |
| Beck, JF | 1 |
2 other studies available for vorinostat and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Ependymoma; Gene Expression Profiling; Histone Deac | 2011 |
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
Topics: Acetylation; Apoptosis; Butyrates; Caspase 3; Caspase 9; DNA Fragmentation; Enzyme Activation; Histo | 2006 |